Comparative characterization of cultures of primary human macrophages or dendritic cells relevant to biomaterial studies

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 2, 2010, Pages 791-800

  Shankar, Sucharita P ^a   Babensee, Julia E ^a  

^a Emory University   (United States)

Author keywords

Biomaterials; Dendritic cells; Macrophages; Peripheral blood mononuclear cells

Indexed keywords

ADAPTIVE IMMUNITY; B LYMPHOCYTES; CD4+T-LYMPHOCYTES; CELL POPULATIONS; COMBINATION PRODUCTS; CYTOKINES; DENDRITIC CELLS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS; HOST RESPONSE; HUMAN MACROPHAGES; HUMAN PERIPHERAL BLOOD; IMMUNE CELLS; IN-VITRO TESTS; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MANNOSE RECEPTORS; MEMBRANE PROCESS; PERIPHERAL BLOOD MONONUCLEAR CELLS; PRIMARY CULTURE; WOUND HEALING;

ABERRATIONS; BIOLOGICAL MATERIALS; BIOMATERIALS; BLOOD; CELL PROLIFERATION; CONTROL SURFACES; DENDRIMERS; DRUG PRODUCTS; HARVESTING; MACROPHAGES;

CELL CULTURE;

BIOMATERIAL; CD123 ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD1C ANTIGEN; CD24 ANTIGEN; CD64 ANTIGEN; GLYCOPROTEIN P 15095; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4;

ARTICLE; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE;

ANIMALS; ANTIGEN-PRESENTING CELLS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-4; MACROPHAGES; MATERIALS TESTING; SWINE;

EID: 75149148020     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32406     Document Type: Article

References (62)

1. Babensee JE, Anderson JM, McIntire LV, Mikos AG. Host response to tissue engineered devices. Adv Drug Deliv Rev 1998;33:111-139.
2. Matzelle MM, Babensee JE. Humoral and T cell immune responses to model antigen delivered with biomaterials used in tissue engineering. Biomaterials 2004;25:295-304.
3. McNally AK, Anderson JM. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995;147:1487-1499.
4. Gordon S. Pattern recognition receptors: Doubling up for the innate immune response. Cell 2002;111:927-930.
5. Xia Z, Triffitt JT. A review on macrophage responses to biomaterials. Biomed Mater 2006;1:R1-R9.
6. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
7. Setum CM, Serie JR, Hegre OD. Comparative analysis of potency of splenic dendritic and adherent cells (macrophages) as alloantigen presenters in vivo. Diabetes 1991;40:1719-1724.
8. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.
9. Triozzi PL, Aldrich W. Phenotypic and functional differences between dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages. J Leukoc Biol 1997;61:600-608.
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
11. Janeway CAJ, Medzhitov R. Introduction: The role of innate immunity in the adaptive immune response. Semin Immunol 1998;10:349-350.
12. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
13. Singh M, O'Hagan D. Advances in vaccine adjuvants. Nat Biotechnol 1999;17:1075-1081.
14. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T. Maturation of human dendritic cells by cell wall cytoskeleton of Mycobacterium bovis bacillus Calmette-Guerin: Involvement of toll-like receptors. Infect Immun 2000;68:6883-6890.
15. Newman KD, Elamanchili P, Kwon GS, Samuel J. Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. J Biomed Mater Res 2002;60:480-486.
16. Stivaktakis N, Nikou K, Panagi Z, Beletsi A, Leondidadis L, Avgoustakis K. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly (lactic-co-glycolic acid) microspheres. J Biomed Mater Res A 2005;73:332-338.
17. Bennewitz NL, Babensee JE. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen. Biomaterials 2005; 26:2991-2999.
18. Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A 2004;71:45-54.
19. Babensee JE, Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 2005;74:503-510.
20. Yoshida M, Babensee JE. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. J Biomed Mater Res A 2006;79:393-408.
21. Yoshida M, Babensee JE. Molecular aspects of microparticle phagocytosis by dendritic cells. J Biomater Sci Polym Ed 2006;17:893-907.
22. McNally AK, DeFife KM, Anderson JM. Interleukin-4-induced macrophage fusion is prevented by inhibitors of mannose receptor activity. Am J Clin Pathol 1996;149:975-985.
23. McInnes A, Rennick DM. Interleukin-4 induces cultured monocytes, macrophages to form giant multinucleated cells. J Exp Med 1988;167:598-611.
24. DeFife KM, Jenney CR, McNally AK, Colton E, Anderson JM. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression. J Immunol 1997;158:3385-3390.
25. Xu H, Kramer M, Spengler HP, Peters JH. Dendritic cells differentiated from human monocytes through a combination of IL-4. GM-CSF and IFN-gamma exhibit phenotype and function of blood dendritic cells. Adv Exp Med Biol 1995;378: 75-78.
26. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996;196:121-135.
27. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eible B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J Immunol Methods 1996;196: 137-151.
28. Zou GM, Tam YK. Cytokines in the generation and maturation of dendritic cells: Recent advances. Eur Cytokine Netw 2002;13:186-199.
29. Tang LL, Zhang Z, Zheng JS, Sheng JF, Liu KZ. Phenotypic and functional characteristics of dendritic cells derived from human peripheral blood monocytes. J Zhejiang Univ Sci B 2005;6:1176-1181.
30. Santin AD, Hermonat PL, Ravaggi A, Chiriva-Internati M, Cannon MJ, Hiserodt JC, Pecorelli S, Parham GP. Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro. Immunobiology 1999;200:187-204.
31. Pickl WF, Majdic O, Kohl P, Stockl J, Reidl E, Scheinecker C, Bello-Fernandez C, Knapp W. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J Immunol 1996;157: 3850-3859.
32. Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle HP, Walter E. Evaluation of particle uptake in human blood monocytes-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Cont Release 2001;76:59-71.
33. Thiele L, Merkle HP, Walter E. Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages. Pharm Res 2003;20:221-228.
34. Bryant P, Ploegh H. Class II MHC peptide loading by the professionals. Curr Opin Immunol 2004;16:96-102.
35. Werling D, Hope JC, Howard CJ, Jungi TW. Differential production of cytokines, reactive oxygen and nitrogen by bovine macrophages and dendritic cells stimulated with Toll-like receptor agonists. Immunology 2004;111:41-52.
36. Guidos C, Wong M, Lee KC. A comparison of the stimulatory activities of lymphoid dendritic cells and macrophages in T proliferative responses to various antigens. J Immunol 1984;133:1179-1184.
37. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 1996;157:1406-1414.
38. Hoves S, Krause SW, Schutz C, Halbritter D, Scholmerich J, Herfarth H, Fleck M. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol 2006;177:2691-2698.
39. Shankar SP, Keselowsky BG, Garcia AJ, Babensee JE. Dendritic cell responses to self-assembled monolayers of defined chemistries. Submitted for publication.
40. McNally AK, Anderson JM. Beta1 and beta2 integrins mediate adhesion during macrophage fusion and multinucleated foreign body giant cell formation. Am J Pathol 2002;160:621-630.
41. Brodbeck WG, Nakayama Y, Matsuda T, Colton E, Ziats NP, Anderson JM. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro. Cytokine 2002;18:311-319.
42. Brodbeck WG, MacEwan M, Colton M, Meyerson H, Anderson JM. Lymphocytes and the foreign body response: Lymphocyte enhancement of macrophage adhesion and fusion. J Biomed Mater Res A 2005;74:222-229.
43. Jones JA, Dadsetan M, Collier TA, Ebert M, Stokes KS, Ward RS, Hiltner PA, Anderson JM. Macrophage behavior on surface-modified polyurethanes. J Biomater Sci Polym Ed 2004; 15:567-584.
44. Cao X, Sugita M, Van Der Wel N, Lai J, Rogers RA, Peters PJ, Brenner MB. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J Immunol 2002;169: 4770-4777.
45. van der Wel NN, Sugita M, Fluitsma DM, Cao X, Schreibelt G, Brenner MB, Peters PJ. CD1 and major histocompatibility complex II molecules follow a different course during dendritic cell maturation. Mol Biol Cell 2003;14:3378-3388.
46. Kushnir N, Liu L, MacPherson G. Dendritic cells and resting B cells form clusters in vitro and in vivo: T cell independence, partial LFA-1 dependance and regulation by cross-linking surface molecules. J Immunol 1998;160:1774-1781.
47. Inaba K, Steinman RM. Monoclonal antibodies to LFA-1 and to CD4 inhibit the mixed leukocyte reaction after the antigendependent clustering of dendritic cells and T lymphocytes. J Exp Med 1987;165:1403-1417.
48. Donaghy H, Pozniak A, Gazzard B, Qazi N, Gilmour J, Gotch F, Patterson S. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001;98:2574-2576.
49. Bayry J, Lacroix-Desmazes S, Donkova-Petrini V, Carbonneil C, Misra N, Lepelletier Y, Delignat S, Varambally S, Oksenhendler E, Le Y, Debré M, Kazatchkine MD, Hermine O, Kaveri SV. Natural antibodies sustain differentiation and maturation of human dendritic cells. Proc Natl Acad Sci USA 2004;101:14210-14215.
50. Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Hermine O, Tough DF, Kaveri SV. Modulation of dendritic cell maturation and function by B lymphocytes. J Immunol 2005;175: 15-20.
51. Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ, Maliszewski C, Lindberg FP, Oldenborg A, Ullrich A, Delespesse G, Sarfati M. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-α: Down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. J Immunol 2001;167:2547-2554.
52. Johansson U, Londei M. Ligation of CD47 during monocytes differentiation into dendritic cells results in reduced capacity for interleukin-12 production. Scand J Immunol 2004;59: 50-57.
53. Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL. Blocking CD40-CD154 and CD80/CD86-CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production. Eur J Immunol 1999;29:2367-2375.
54. Lenschow DJ, Su GH, Zuckerman LA, Nabavi N, Jellis CL, Gray GS, Miller J, Bluestone JA. Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci USA 1993;90:11054-11058.
55. MacEwan MR, Brodbeck WG, Matsuda T, Anderson JM. Monocyte/lymphocyte interactions and the foreign body response: In vitro effects of biomaterial surface chemistry. J Biomed Mater Res A 2005;74:285-293.
56. Wu L, Kewal Ramani VN. Dendritic-cell interactions with HIV: Infection and viral dissemination. Nat Rev Immunol 2006;6:859-868.
57. Fazle Akbar SM, Abe M, Yoshida O, Murakami H, Onji M. Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: Present limitations and future scopes. Curr Med Chem 2006;13:3113-3119.
58. Rubakova E, Petrovskaya S, Pichugin A, Khlebnikov V, McMurray D, Kondratieva E, Baturina I, Kondratieva T, Apt A. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model. Tuberculosis 2007;87:134-144.
59. Zvaifler NJ, Steinman RM, Kaplan G, Lau LL, Rivelis M. Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis. J Clin Invest 1985;76:789-800.
60. Duddy ME, Dickson G, Hawkins SA, Armstrong MA. Monocyte-derived dendritic cells: A potential target for therapy in multiple sclerosis (MS). Clin Exp Immunol 2001;123:280-287.
61. Knijff EM, Ruwhof C, de Wit HJ, Kupka RW, Vonk R, Akkerhuis GW, Nolen WA, Drexhage HA. Monocyte-derived dendritic cells in bipolar disorder. Biol Psychiatry 2006;59:317-326.
62. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005;23:47-55.